The management of a pregnant patient with malaria in West Texas

  • Hanna Kodeih
  • James Maher
  • Natalia Schlabritz-Lutsevich

Abstract

Travel associated infectious disease, such as malaria, should be considered in returning travelers from an endemic area presenting with fever. Malaria in pregnancy has a high maternal and fetal morbidity and mortality burden. Early diagnosis is essential to improve maternal and fetal outcomes by providing maternal supportive measures and anti-malarial medication.

We present a patient with severe acute febrile illness with mental status changes at 32 weeks gestation. She became acutely symptomatic including high grade fever while visiting West Texas from Nigeria. Despite initial diagnostic uncertainty, a multidisciplinary team successfully diagnosed and treated her severe malaria. She delivered at term with no long lasting maternal or fetal sequelae from her malarial infection. In an age of globalization, travel associated infectious diseases should be considered in the differential of acute febrile illness in pregnant women.

Keywords: obstetrics, malaria, critical care in pregnancy

Downloads

Download data is not yet available.

References

Angelo KM, Libman M, Caumes E, et al. Malaria after international

travel: a GeoSentinel analysis, 2003–2016. Malar J

;16(1):293.

Imperato PJ. The convergence of a virus, mosquitoes, and

human travel in globalizing the Zika epidemic, 2016. J Community

Health; 41(3):674–9.

Harvey K, Esposito DH, Han P, et al. Surveillance for travelrelated

disease-GeoSentinel Surveillance System, United

States, 1997-2011. MMWR Surveill Summ 2013;62:1–23.

Whitty CJ, Edmonds S, Mutabingwa TK. Malaria in pregnancy.

BJOG 2005;112(9):1189–95.

Espinoza E, Hidalgo L, Chedraui P. The effect of malarial

infection on maternal-fetal outcome in Ecuador. J Matern

Fetal Neonatal Med 2005;18(2):101–5.

Granja AC, Machungo F, Gomes A, et al. Malaria-related

maternal mortality in urban Mozambique. Ann Trop Med

Parasitol 1998;92(3):257–63.

Severe malaria. Trop Med Int Health 2014;19 Suppl 1:7–131.

Burger RJ, van Eijk AM, Bussink M, et al. Artemisinin-based

combination therapy versus quinine or other combinations for

treatment of uncomplicated Plasmodium falciparum malaria in

the second and third trimester of pregnancy: a systematic review

and meta-analysis. Open Forum Infect Dis. 2016;12;3(1): ofv170.

Newman RD, Hailemariam A, Jimma D, et al. Burden of

malaria during pregnancy in areas of stable and unstable

transmission in Ethiopia during a nonepidemic year. J Infect

Dis 2003;187(11):1765–72.

Uneke CJ. Congenital Plasmodium falciparum malaria in

sub-Saharan Africa: a rarity or frequent occurrence? Parasitol

Res 2007;101(4):835–42.

Griffin JB, Lokomba V, Landis SH, et al. Plasmodium falciparum

parasitaemia in the first half of pregnancy, uterine and

umbilical artery blood flow, and foetal growth: a longitudinal

Doppler ultrasound study. Malar J 2012;11:319.

Kattenberg JH, Ochodo EA, Boer KR, et al. Systematic

review and meta-analysis: rapid diagnostic tests versus placental

histology, microscopy and PCR for malaria in pregnant

women. Malar J 2011;10:321.

Malaria. World Health Organization. http://www.who.int/

malaria/en/. Accessed 11/30/2018.

White NJ, Pukrittayakamee S, Hien TT, et al. Malaria. Lancet

;383(9918):723–35.

Frean J. Improving quantitation of malaria parasite burden

with digital image analysis. Trans R Soc Trop Med Hyg 2008;

(11):1062–3.

Peixoto HM, Marchesini PB, de Oliveria MR. Efficacy

and safety of artesunate-mefloquine therapy for treating

uncomplicated Plasmodium falciparum malaria: systematic

review and meta-analysis. Trans R Soc Trop Med Hyg

Guidelines for Treatment of Malaria in the United States.

Centers for Disease Control. https://www.cdc.gov/malaria/

resources/pdf/treatmenttable.pdf. Accessed 11/30/2018.

Mehta SR, Das S. Management of malaria: recent trends.

J Commun Dis 2006;38(2):130–8.

Olliaro P. Mode of action and mechanisms of resistance for

antimalarial drugs. Pharmacol Ther 2001;89(2):207–19.

Rosenthal PJ. Antiprotozoal drugs. In: Katzung BG, Masters

SB, Trevor AJ, editors. Basic & Clinical Pharmacology, 14e

New York, NY: McGraw-Hill; 2017.

Olliaro P. Mode of action and mechanisms of resistance for

antimalarial drugs. Pharmacol Ther 2001;89(2):207–19.

Artesunate is available to treat severe malaria in the United

States. Centers for Disease Control. https://www.cdc.gov/malaria/

diagnosis_treatment/artesunate.html. Accessed 11/30/2018.

Mace KE, Arguin PM, Tan KR. Malaria Surveillance—United

States, 2015. MMWR Surveill Summ 2018;67(No. SS-7):

–28. DOI: http://dx.doi.org/10.15585/mmwr.ss6707a1

Critical care in pregnancy. Obstet Gynecol 2016;128(4):

e147–54.

Published
2019-04-19
How to Cite
Kodeih, H., Maher, J., & Schlabritz-Lutsevich, N. (2019). The management of a pregnant patient with malaria in West Texas. The Southwest Respiratory and Critical Care Chronicles, 7(28), 47-52. https://doi.org/10.12746/swrccc.v7i28.545